# Moderato System in Patients With Hypertension

Study · id `cardio:ct-nct03757377` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03757377](<https://clinicaltrials.gov/study/NCT03757377>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03757377

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 203 participants.

## Technical summary

Registry record NCT03757377. Randomized; double masking; primary purpose treatment. Start 2017-08-30 (actual); primary completion 2021-05-13 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 203 participants (enrolled count; ClinicalTrials.gov record NCT03757377, source copy `cardio:ctgov-nct03757377-2026-06-18`, retrieved 2026-10-26)
- Started: 2017-08-30 (actual) (ClinicalTrials.gov record NCT03757377, source copy `cardio:ctgov-nct03757377-2026-06-18`, retrieved 2026-10-26)
- Primary completion: 2021-05-13 (actual) (ClinicalTrials.gov record NCT03757377, source copy `cardio:ctgov-nct03757377-2026-06-18`, retrieved 2026-10-26)
- Completion: 2021-05-13 (actual) (ClinicalTrials.gov record NCT03757377, source copy `cardio:ctgov-nct03757377-2026-06-18`, retrieved 2026-10-26)
- Countries: Belgium; Lithuania; Poland (ClinicalTrials.gov record NCT03757377, source copy `cardio:ctgov-nct03757377-2026-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03757377-2026-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Moderato System in Patients With Hypertension
- Condition: Hypertension, Resistant to Conventional Therapy
- Condition: Atrioventricular Block
- Intervention (Device): BackBeat Moderato System
- Intervention (Device): BackBeat Moderato Sytsem
- Lead sponsor: BackBeat Medical Inc
- Lead sponsor class: INDUSTRY
- Collaborator: Massachusetts General Hospital
- Collaborator class: OTHER
- Collaborator: MLM Medical Labs GmbH
- Collaborator class: INDUSTRY
- Collaborator: nabios GmbH
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart block (`cardio:heart-block`)
- Registry lists this organization as a collaborator: Massachusetts General Hospital (`cardio:org-massachusetts-general-hospital`)

## Provenance

Content hash: 1c6926e68a113d081447e4b8d4a72c4235ee6bae47e7913beb15592970ff3571
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
